Komipharm International Co., Ltd. (KOSDAQ:041960)

Komipharm International Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	435,517	267,413	293,942	446,056	548,450	858,749
Market Cap Growth	54.40%	-9.03%	-34.10%	-18.67%	-36.13%	-11.44%
Enterprise Value	458,417	289,788	324,970	476,056	565,527	878,631
Last Close Price	6060.00	3860.00	4190.00	6350.57	7804.20	12219.61
PE Ratio	103.54	20.39	-	-	-	-
PS Ratio	7.95	4.55	6.89	11.21	15.30	23.11
PB Ratio	6.15	4.08	4.90	6.80	7.58	11.00
P/TBV Ratio	6.58	4.43	5.22	7.36	8.26	11.27
P/FCF Ratio	184.09	34.28	-	-	-	-
P/OCF Ratio	120.07	30.23	-	-	-	34076.71
EV/Sales Ratio	8.36	4.93	7.62	11.96	15.78	23.64
EV/EBITDA Ratio	70.96	31.18	-	21308.58	-	561.53
EV/EBIT Ratio	134.48	46.79	-	-	-	-
EV/FCF Ratio	193.77	37.14	-	-	-	-
Debt / Equity Ratio	0.55	0.67	0.75	0.58	0.46	0.46
Debt / EBITDA Ratio	6.04	4.72	-	1706.78	-	22.80
Debt / FCF Ratio	16.50	5.62	-	-	-	-
Asset Turnover	0.45	0.49	0.37	0.35	0.30	0.30
Inventory Turnover	2.49	2.52	1.93	1.87	1.77	1.83
Quick Ratio	0.92	0.83	0.52	0.53	0.93	0.72
Current Ratio	1.52	1.30	0.96	1.01	1.61	1.14
Return on Equity (ROE)	8.55%	23.40%	-9.41%	-10.84%	-7.89%	-5.13%
Return on Assets (ROA)	1.74%	3.21%	-3.40%	-2.09%	-2.79%	-1.10%
Return on Capital (ROIC)	1.96%	3.61%	-3.75%	-2.27%	-3.01%	-1.18%
Return on Capital Employed (ROCE)	4.10%	8.10%	-	-	-	-
Earnings Yield	0.94%	4.90%	-1.35%	-1.46%	-0.81%	-0.33%
FCF Yield	0.54%	2.92%	-1.17%	-0.60%	-0.38%	-0.19%
Buyback Yield / Dilution	-0.50%	0.66%	0.18%	-0.01%	-0.09%	-0.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.